Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
539.9 USD | +0.07% | +1.47% | -2.72% |
Mar. 11 | Idexx Laboratories: Superior growth prospects | |
Mar. 07 | Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing | MT |
Evolution of the average Target Price on IDEXX Laboratories, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering IDEXX Laboratories, Inc.
JPMorgan Chase | |
Stifel Nicolaus | |
Barclays | |
Morgan Stanley | |
Piper Sandler | |
Goldman Sachs | |
Atlantic Equities | |
BofA Securities | |
Credit Suisse | |
Guggenheim | |
J.P. Morgan Chase |
EPS Revisions
- Stock
- Equities
- Stock IDEXX Laboratories, Inc. - Nasdaq
- Consensus IDEXX Laboratories, Inc.